BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI
6149 results:

  • 1. Peak Resembling N-acetylaspartate (NAA) on Magnetic Resonance Spectroscopy of brain Metastases.
    Ostojic J; Kozic D; Panjkovic M; Georgievski-Brkic B; Dragicevic D; Lovrenski A; Boban J
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674308
    [No Abstract]    [Full Text] [Related]  

  • 2. Prognosis versus Actual Outcomes in Stereotactic Radiosurgery of brain Metastases: Reliability of Common Prognostic Parameters and Indices.
    Mangesius J; Seppi T; Arnold CR; Mangesius S; Kerschbaumer J; Demetz M; Minasch D; Vorbach SM; Sarcletti M; Lukas P; Nevinny-Stickel M; Ganswindt U
    Curr Oncol; 2024 Mar; 31(4):1739-1751. PubMed ID: 38668035
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Simultaneous boost radiotherapy versus conventional dose radiotherapy for patients with newly diagnosed glioblastoma: a multi-institutional analysis.
    Takano S; Tomita N; Kuno M; Niwa M; Torii A; Takaoka T; Kita N; Okazaki D; Yamamoto S; Kawai T; Sugie C; Ogawa Y; Matsumoto K; Uchiyama K; Otsuka S; Matsui T; Miyakawa A; Mizuno T; Iida M; Tanikawa M; Mase M; Hiwatashi A
    Sci Rep; 2024 Apr; 14(1):9283. PubMed ID: 38654028
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diffusion- and Perfusion-Weighted MRI Radiomics for Survival Prediction in Patients with Lower-Grade Gliomas.
    Park CJ; Kim S; Han K; Ahn SS; Kim D; Park YW; Chang JH; Kim SH; Lee SK
    Yonsei Med J; 2024 May; 65(5):283-292. PubMed ID: 38653567
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Fully Automatic Glioma Segmentation Algorithm of Magnetic Resonance Imaging Based on 3D-UNet With More Global Contextual Feature Extraction: An Improvement on Insufficient Extraction of Global Features].
    Tian H; Wang Y; Ji Y; Rahman MM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):447-454. PubMed ID: 38645864
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Analysis of the safety, accuracy, and factors influencing bleeding complications in CT-guided puncture biopsy of brain occupying lesions].
    Li YD; Gao MY; Wang M; Gao F; Liu YQ; Du KP; Li S; Zhang HJ; Yao YF; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1403-1409. PubMed ID: 38644291
    [No Abstract]    [Full Text] [Related]  

  • 7. Double pituitary adenomas: report of two cases and systematic review of the literature.
    Zhang Y; Gong X; Pu J; Liu J; Ye Z; Zhu H; Lu L; Pan H; Deng K; Yao Y
    Front Endocrinol (Lausanne); 2024; 15():1373869. PubMed ID: 38628582
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. B7-H3 Expression in Breast cancer and brain Metastasis.
    Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Amide proton transfer weighted and diffusion weighted imaging based radiomics classification algorithm for predicting 1p/19q co-deletion status in low grade gliomas.
    Ma A; Yan X; Qu Y; Wen H; Zou X; Liu X; Lu M; Mo J; Wen Z
    BMC Med Imaging; 2024 Apr; 24(1):85. PubMed ID: 38600452
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E.
    Chen MF; Song Z; Yu HA; Sequist LV; Lovly CM; Mitchell EP; Moscow JA; Gray RJ; Wang V; McShane LM; Rubinstein LV; Patton DR; Williams PM; Hamilton SR; Umemura Y; Tricoli JV; Conley BA; Arteaga CL; Harris LN; O'Dwyer PJ; Chen AP; Flaherty KT
    JCO Precis Oncol; 2024 Apr; 8():e2300454. PubMed ID: 38591867
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Perifocal edema is a risk factor for preoperative seizures in patients with meningioma WHO grade 2 and 3.
    Teske N; Teske NC; Greve T; Karschnia P; Kirchleitner SV; Harter PN; Forbrig R; Tonn JC; Schichor C; Biczok A
    Acta Neurochir (Wien); 2024 Apr; 166(1):170. PubMed ID: 38581569
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer.
    Divan HA; Bittoni MA; Krishna A; Carbone DP
    BMC Cancer; 2024 Apr; 24(1):424. PubMed ID: 38580900
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Treatment of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM).
    Benetti-Pinto CL; Prestes Nácul A; Rosa-E-Silva ACJS; Maciel GAR; Dos Santos Nunes Nogueira V; Condé Lamparelli Elias P; Martins M; Kasuki L; Mendes Garmes H; Glezer A
    Arch Endocrinol Metab; 2024 Apr; 68():e230504. PubMed ID: 38578473
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung cancer: A Meta-Analysis.
    Chi C; Wang C; Dong L; Li X; Xu L
    J Coll Physicians Surg Pak; 2024 Apr; 34(4):461-467. PubMed ID: 38576291
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Relaxation Along a Fictitious Field, continuous wave T1rho, adiabatic T1rho and adiabatic T2rho imaging of human gliomas at 3T: A feasibility study.
    Jambor I; Steiner A; Pesola M; Gardberg M; Frantzén J; Jokinen P; Liimatainen T; Minn H; Aronen H; Merisaari H
    PLoS One; 2024; 19(4):e0296958. PubMed ID: 38558074
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Real-time glioblastoma tumor microenvironment assessment by SpiderMass for improved patient management.
    Zirem Y; Ledoux L; Roussel L; Maurage CA; Tirilly P; Le Rhun É; Meresse B; Yagnik G; Lim MJ; Rothschild KJ; Duhamel M; Salzet M; Fournier I
    Cell Rep Med; 2024 Apr; 5(4):101482. PubMed ID: 38552622
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM].
    Gibson D; Vo AH; Lambing H; Bhattacharya P; Tahir P; Chehab FF; Butowski N
    BMC Neurol; 2024 Mar; 24(1):103. PubMed ID: 38521933
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparison of ASL and DSC perfusion methods in the evaluation of response to treatment in patients with a history of treatment for malignant brain tumor.
    Bayraktar ES; Duygulu G; Çetinoğlu YK; Gelal MF; Apaydın M; Ellidokuz H
    BMC Med Imaging; 2024 Mar; 24(1):70. PubMed ID: 38519901
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label, non-randomised prospective imaging study.
    Pruis IJ; van Doormaal PJ; Balvers RK; van den Bent MJ; Harteveld AA; de Jong LC; Konijnenberg MW; Segbers M; Valkema R; Verburg FA; Smits M; Veldhuijzen van Zanten SEM
    EBioMedicine; 2024 Apr; 102():105068. PubMed ID: 38518652
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Metabolic impairments associated with type 2 diabetes mellitus and the potential effects of exercise therapy: An exploratory randomized trial based on untargeted metabolomics.
    Zhang F; Chen X; Yang M; Shen X; Wang Y; Zhong D; Zeng F; Jin R
    PLoS One; 2024; 19(3):e0300593. PubMed ID: 38517904
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 308.